by KYW’s Lynne Adkins
Temple University has been named one of five sites nationwide to study treatment for drug-resistant infections.
MRSA, methicillian resistant staphylococcus aureus is more difficult to treat than most common staph infections because it's immune to many of the commonly used antibiotics.
Dr. Robert McNamara, chairman of emergency medicine at Temple University Hospital says doctors will test possible treatments on local patients:
“There are certain cases that will get better no matter what antibiotics you put them on. And the purpose of this study is to show that others need no medicine, just drain the abscess they'll be able to defeat the infection. And others, we know the common antibiotics used for skin and a soft infection, MRSA is generally resistant to them so not only are they not going to work, but you’re taking the risk of the antibiotic for no benefit.”
The study will last five years.
E-Mail Story
Print Story
